Example: barber
A Phase II Study of Weekly Irinotecan and …
A Phase II Study of Weekly Irinotecan and Capecitabine in Patients with Previously Treated Non-Small Cell Lung Cancer Ji-Youn Han, Dae Ho Lee, Hyae Young Kim,
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
X-Tile: A New Bio-Informatics Tool for Biomarker ...
clincancerres.aacrjournals.orgX-Tile: A New Bio-Informatics Tool for Biomarker Assessment and Outcome-Based Cut-Point Optimization Robert L. Camp,1 Marisa Dolled-Filhart,2 and David L. Rimm1 Departments of 1Pathology and 2Genetics, Yale University, School of Medicine, New Haven, Connecticut
A Leukemia-Associated CD34/CD123/CD25/ …
clincancerres.aacrjournals.orgBiology of Human Tumors A Leukemia-Associated CD34/CD123/CD25/ CD99þ Immunophenotype Identifies FLT3- Mutated Clones in Acute Myeloid Leukemia Daniela F. Angelini1,Tiziana Ottone2,3, Gisella Guerrera1, Serena Lavorgna2,3,
CCR FOCUS - Clinical Cancer Research
clincancerres.aacrjournals.orgApproaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force
Panobinostat for the Treatment of Multiple Myeloma
clincancerres.aacrjournals.orgPanobinostat for the Treatment of Multiple Myeloma Jacob P. Laubach1, Philippe Moreau2, ... dexamethasone to treat patients with multiple myeloma who have received 2 prior regimens, including bortezomib and an ... was investigated for the treatment of multiple myeloma, and
Molecular Pathways: Activating T Cells after Cancer Cell ...
clincancerres.aacrjournals.orgMolecular Pathways Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 "Don't Eat Me" Signals Melissa N. McCracken1,2,3, Adriel C. Cha1,2,3,4, and Irving L.Weissman1,2,3,5 Abstract
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study ...
clincancerres.aacrjournals.orgCancer Therapy: Clinical Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888)
Strategies for Enzyme/Prodrug Cancer Therapy
clincancerres.aacrjournals.orgMinireview Strategies for Enzyme/Prodrug Cancer Therapy1 Guang Xu and Howard L. McLeod2 Washington University School of Medicine, Departments of …
Results from an Integrated Safety Analysis of Urelumab, an ...
clincancerres.aacrjournals.orgCancer Therapy: Clinical Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody Neil H. Segal1,Theodore F. Logan2, F ...
Related documents
American Thyroid Association Guidelines for …
www.thyca.orgTHYROID CANCER AND NODULES American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer Robert C. Smallridge,1,* Kenneth B. Ain,2,3 Sylvia L. Asa,4,5 Keith C. Bible,6 James D. Brierley,4,5
Palliative Performance Scale (PPSv2)
palliative.infoPalliative Performance Scale (PPSv2) version 2 PPS Level Ambulation Activity & Evidence of Disease Self-Care Intake Conscious Level 100% Full Normal activity & work